Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
11.22
-0.66 (-5.56%)
At close: May 15, 2026, 4:00 PM EDT
11.00
-0.22 (-1.96%)
After-hours: May 15, 2026, 4:57 PM EDT

Xencor Revenue

Xencor had revenue of $4.52M in the quarter ending March 31, 2026, a decrease of -86.20%. This brings the company's revenue in the last twelve months to $97.36M, down -32.60% year-over-year. In the year 2025, Xencor had annual revenue of $125.58M with 13.65% growth.

Revenue (ttm)
$97.36M
Revenue Growth
-32.60%
P/S Ratio
9.05
Revenue / Employee
$374,462
Employees
260
Market Cap
831.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025125.58M15.08M13.65%
Dec 31, 2024110.49M-64.12M-36.72%
Dec 31, 2023174.62M10.04M6.10%
Dec 31, 2022164.58M-110.53M-40.18%
Dec 31, 2021275.11M152.42M124.23%
Dec 31, 2020122.69M-34.01M-21.70%
Dec 31, 2019156.70M116.10M285.93%
Dec 31, 201840.60M-5.55M-12.02%
Dec 31, 201746.15M-62.87M-57.67%
Dec 31, 2016109.02M81.26M292.70%
Dec 31, 201527.76M18.24M191.62%
Dec 31, 20149.52M-652.00K-6.41%
Dec 31, 201310.17M648.00K6.80%
Dec 31, 20129.52M2.68M39.06%
Dec 31, 20116.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Geron196.12M
Arbutus Biopharma191.45M
Kura Oncology71.64M
Janux Therapeutics13.73M
Absci1.84M
Revenue Rankings